Home/Pipeline/Undisclosed Candidate 1

Undisclosed Candidate 1

Oncology/Autoimmune

ClinicalActive

Key Facts

Indication

Oncology/Autoimmune

Phase

Clinical

Status

Active

Company

Abogen

About Abogen

A fully integrated clinical-stage biotech company developing transformative mRNA medicines for oncology, autoimmune diseases, and infectious diseases.

View full company profile

Therapeutic Areas

Oncology Immunology Infectious Diseases

Other Oncology/Autoimmune Drugs

Drug	Company	Phase	Status
Undisclosed Candidate 2	Abogen	Clinical	Active